CDKL5 and epilepsy: To date, several studies have used brain organoids to study CDD-associated epilepsy, showing that CDKL5 disruption leads to hyperexcitability of glutamatergic neurons and hypersynchronous neuronal activity associated with epilepsy [102,129].